Overview

Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses

Status:
Recruiting
Trial end date:
2024-11-02
Target enrollment:
Participant gender:
Summary
Prospective, non-blinded, randomised two cohorts study on the efficacy of two different radiotherapy schedule for DIPG by using the same concomitant and post-radiotherapy systemic treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborators:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Johannes Gutenberg University Mainz
University of Roma La Sapienza
Wuerzburg University Hospital
Treatments:
Antibodies, Monoclonal
Nimotuzumab
Vinorelbine